Can Pancreastatin Levels Guide Therapy in NETS Patients Undergoing TACE?

For patients with NETs that have metastasized to the liver, high levels of serum pancreastatin are predictive of poor outcomes after treatment with TACE.

Source: CancerNetwork - September 20, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news